W. Doering

1.2k total citations
39 papers, 790 citations indexed

About

W. Doering is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, W. Doering has authored 39 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 14 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in W. Doering's work include Ion channel regulation and function (12 papers), Cardiac electrophysiology and arrhythmias (11 papers) and Cardiovascular Function and Risk Factors (7 papers). W. Doering is often cited by papers focused on Ion channel regulation and function (12 papers), Cardiac electrophysiology and arrhythmias (11 papers) and Cardiovascular Function and Risk Factors (7 papers). W. Doering collaborates with scholars based in Germany and Switzerland. W. Doering's co-authors include G. G. Belz, Franz X. Kleber, Oliver Schnell, Wolfgang Otter, Eberhard Standl, E. König, B. Fichtl, Oliver Schäfer, Martin J. Herrmann and Wojciech Maciejewski and has published in prestigious journals such as New England Journal of Medicine, Diabetes Care and The American Journal of Cardiology.

In The Last Decade

W. Doering

37 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Doering Germany 15 494 171 133 102 88 39 790
Pertti J. Pentikäinen Finland 18 466 0.9× 157 0.9× 112 0.8× 126 1.2× 56 0.6× 32 937
John A. Opsahl United States 17 457 0.9× 200 1.2× 206 1.5× 129 1.3× 121 1.4× 48 1.1k
Bernard E. Ilson United States 17 360 0.7× 96 0.6× 66 0.5× 204 2.0× 50 0.6× 33 825
Yin‐Gail Yee United States 12 217 0.4× 77 0.5× 76 0.6× 57 0.6× 56 0.6× 16 510
Paul A. Abraham United States 15 204 0.4× 74 0.4× 74 0.6× 95 0.9× 110 1.3× 34 854
Knud Erik Pedersen Denmark 17 386 0.8× 106 0.6× 164 1.2× 45 0.4× 164 1.9× 45 880
Mitsutaka Kanamaru Japan 15 159 0.3× 140 0.8× 71 0.5× 79 0.8× 42 0.5× 44 698
KL Woods United Kingdom 14 355 0.7× 68 0.4× 119 0.9× 35 0.3× 51 0.6× 40 769
Iris Rajman Switzerland 17 372 0.8× 91 0.5× 107 0.8× 221 2.2× 46 0.5× 31 885
J J Lima United States 18 109 0.2× 161 0.9× 154 1.2× 45 0.4× 78 0.9× 35 707

Countries citing papers authored by W. Doering

Since Specialization
Citations

This map shows the geographic impact of W. Doering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Doering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Doering more than expected).

Fields of papers citing papers by W. Doering

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Doering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Doering. The network helps show where W. Doering may publish in the future.

Co-authorship network of co-authors of W. Doering

This figure shows the co-authorship network connecting the top 25 collaborators of W. Doering. A scholar is included among the top collaborators of W. Doering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Doering. W. Doering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Otter, Wolfgang, Michael G. Winter, W. Doering, Eberhard Standl, & Oliver Schnell. (2007). C-Reactive Protein in Diabetic and Nondiabetic Patients With Acute Myocardial Infarction. Diabetes Care. 30(12). 3080–3082. 9 indexed citations
2.
Otter, Wolfgang, et al.. (2004). Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus. Diabetic Medicine. 21(2). 183–187. 51 indexed citations
3.
Schnell, Oliver, et al.. (2004). Intensification of Therapeutic Approaches Reduces Mortality in Diabetic Patients With Acute Myocardial Infarction. Diabetes Care. 27(2). 455–460. 52 indexed citations
4.
Kleber, Franz X., Georg Sabin, U. J. Winter, et al.. (1997). Angiotensin-Converting Enzyme Inhibitors in Preventing Remodeling and Development of Heart Failure After Acute Myocardial Infarction. The American Journal of Cardiology. 80(3). 162A–167A. 14 indexed citations
5.
Markewitz, Andreas, et al.. (1995). Determinants of Dual Chamber Pulse Generators Longevity. Pacing and Clinical Electrophysiology. 18(12). 2116–2120. 8 indexed citations
6.
Kleber, Franz X., et al.. (1992). Mechanisms Involved in Cardiac Enlargement and Congestive Heart Failure Development after Acute Myocardial Infarction. Cardiology. 81(4-5). 213–220. 12 indexed citations
7.
Kleber, Franz X., et al.. (1991). Influence of severity of heart failure on the efficacy of angiotensin-converting enzyme inhibition. The American Journal of Cardiology. 68(14). 121–126. 18 indexed citations
8.
Mayer, Wolfgang J., Bettina Wilske, V. Preac‐Mursic, et al.. (1990). Persistent atrioventricular block in Lyme borreliosis. Journal of Molecular Medicine. 68(8). 431–435. 30 indexed citations
9.
Doering, W., et al.. (1990). [Progressive left ventricular dilatation following anterior myocardial infarct as a determinant for the development of heart failure].. PubMed. 79(1). 1–7. 4 indexed citations
10.
Ziegler, A G, et al.. (1988). Left ventricular relaxation and filling pattern in diabetic heart muscle disease: An echocardiographic study. Journal of Molecular Medicine. 66(17). 773–778. 10 indexed citations
11.
Doering, W., et al.. (1987). Pharmacokinetic interaction study with ramipril and digoxin in healthy volunteers. The American Journal of Cardiology. 59(10). D60–D64. 16 indexed citations
12.
Schäfer, S. G., et al.. (1985). Influence of quinidine on the intestinal secretion of digoxin and digitoxin in guinea pigs. Chemico-Biological Interactions. 55(1-2). 203–213. 7 indexed citations
13.
Doering, W., et al.. (1983). [Effect of tiaprofenic acid on serum digoxin concentration].. PubMed. 33(1). 167–8. 6 indexed citations
14.
Fichtl, B. & W. Doering. (1983). The Quinidine-Digoxin Interaction in Perspective. Clinical Pharmacokinetics. 8(2). 137–154. 14 indexed citations
15.
Doering, W., et al.. (1982). Quinidine-digoxin interaction: Evidence for involvement of an extrarenal mechanism. European Journal of Clinical Pharmacology. 21(4). 281–285. 22 indexed citations
16.
Doering, W. & G. G. Belz. (1981). Quinidine-digoxin interaction: Effect of quinidine on86Rb-uptake of human erythrocytes. Journal of Molecular Medicine. 59(2). 95–96. 9 indexed citations
17.
Doering, W.. (1979). Quinidine-Digoxin Interaction. New England Journal of Medicine. 301(8). 400–404. 161 indexed citations
18.
Doering, W., et al.. (1978). Vereinfachte Serum-Digoxin-Bestimmung mit einem Jod-125-Solid-Phase-Test. Journal of Molecular Medicine. 56(10). 497–502. 2 indexed citations
19.
Doering, W., E. König, & Walter Sturm. (1977). [Digitalis intoxication: specifity and significance of cardiac and extracardiac symptoms. part I: Patients with digitalis-induced arrhythmias (author's transl)].. PubMed. 66(3). 121–8. 9 indexed citations
20.
Doering, W., et al.. (1964). [ROUTINE MORPHOLOGICAL DIAGNOSIS OF THE PLACENTA].. PubMed. 106. 1849–55. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pertti J. Pentikäinen Breakdown of academic impact, for papers by John A. Opsahl Breakdown of academic impact, for papers by Bernard E. Ilson Breakdown of academic impact, for papers by Yin‐Gail Yee Breakdown of academic impact, for papers by Paul A. Abraham Breakdown of academic impact, for papers by Knud Erik Pedersen Breakdown of academic impact, for papers by Mitsutaka Kanamaru Breakdown of academic impact, for papers by KL Woods Breakdown of academic impact, for papers by Iris Rajman Breakdown of academic impact, for papers by J J Lima
Rankless by CCL
2026